Search Orphan Drug Designations and Approvals
-
| Generic Name: | Allogeneic Human Pancreatic Islets of Langerhans |
|---|---|
| Date Designated: | 07/22/2019 |
| Orphan Designation: | Treatment of Brittle Type 1 Diabetes |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Hospital of the University of Pennsylvania (Penn Medicine) 3400 Spruce Street 2 Ravdin Courtyard Philadelphia, Pennsylvania 19104 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







